Anthropic Opened Biology Lab in Bay Area
The firm intends to use AI models to guide automated hardware for physical bench experiments.
Updated on Sept. 18, 2026 in Life Sciences

Live Poll
Do you believe using AI to manage automated biological research is a positive development for healthcare?
Anthropic has established a wet lab in the San Francisco Bay Area to conduct physical biological research. The company plans to use its Claude models to automate robotic hardware for bench tests.
Why it matters
The firm aims to discover therapies for neglected rare illnesses. By demonstrating healthcare breakthroughs, the company seeks to mitigate public skepticism regarding AI safety.
The laboratory utilizes automated robotic hardware to conduct physical bench tests guided by AI models. This facility handles work conducted both in-house and through collaborations with external partners.
The players
Anthropic
This AI safety and research company develops Claude models and focuses on building large-scale artificial intelligence systems.
Eric Kauderer-Abrams
He serves as the head of life sciences at Anthropic and oversees the company's biological research initiatives.
The details
The facility is not designated strictly for drug discovery and supports a broader range of biological research. Researchers use Claude models to direct robots during the physical testing process.
Timeline
September 18, 2026: The official announcement of the laboratory facility.
Deeper Dive
The integration of the Claude AI model suite into physical wet lab robotics represents a shift in how language models interact with non-digital research environments. This expansion marks an evolution in the utility of the Claude AI model suite from software-based tasks to physical bench experimentation.
The use of AI to automate physical lab work could accelerate the identification of treatments for rare diseases that were previously too costly or time-consuming to study. These automated processes may eventually shorten the timeline for bringing new therapies from the lab bench to clinical trials.
The takeaway
Anthropic's move underscores a broader industry push to prove that large language models can provide tangible benefits beyond software applications. Readers can watch for future breakthroughs in rare disease research as these AI-guided laboratory workflows mature.
Further reading
For more information on the evolving intersection of computing and biological research, visit the Life Sciences section.
Live Poll
Do you believe using AI to manage automated biological research is a positive development for healthcare?










